Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708525 · ClinicalTrials.gov registry record · NA
Feasibility Study: Heavy Water Tissue Labeling Protocol
A NA study of Skin Laxity, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT01708525: Completed NA study of Skin Laxity, sponsored by Ulthera.
NCT01708525 is a NA study of Skin Laxity that has completed, run by Ulthera. The registered enrollment target is 2 participants, below the 191-participant average among 10 other Skin Laxity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01708525, a NA study of Skin Laxity, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
Enrolled subjects undergo tissue labeling to evaluate the rate of collagen synthesis in tissue treated with the Ulthera® System compared to control tissue.
Primary Outcome
Resected tissue will be analyzed to determine the rate of collagen synthesis in tissue treated with Ultherapy® compared to non-treated tissue.
Conditions Studied
Interventions
- DEVICE Ulthera® System Treatment
- OTHER Heavy Water
Study Locations (1)
California
- Sasaki Advanced Aesthetic Medical Center - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01708525 record still lists
NCT01708525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 191-participant average among 10 other Skin Laxity trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 2 interventions - of which Ulthera® System Treatment is the first listed.
NCT01708525 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01708525 about?
NCT01708525 is a clinical study titled "Feasibility Study: Heavy Water Tissue Labeling Protocol". Enrolled subjects undergo tissue labeling to evaluate the rate of collagen synthesis in tissue treated with the Ulthera® System compared to control tissue.
What is the current status of trial NCT01708525?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2012-08. Estimated completion is 2013-11.
What conditions does trial NCT01708525 study?
This clinical trial studies the following conditions: Skin Laxity.
What interventions are being tested in trial NCT01708525?
The interventions under investigation include: Ulthera® System Treatment (DEVICE), Heavy Water (OTHER).
Who is sponsoring clinical trial NCT01708525?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01708525 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01708525's enrollment target sits among peer trials
2 11th of 10 the lowest of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia